题名 | Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma. |
作者 | Doi T1, Piha-Paul SA1, Jalal SI1, Saraf S1, Lunceford J1, Koshiji M1, Bennouna J1. |
杂志 | J Clin Oncol |
年|卷|期 | 2018 Jan 1;36(1):61-67 |
页码 | 61-67 |
链接 | http://ascopubs.org/doi/pdf/10.1200/JCO.2017.74.9846 |
多谢大神
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |